CD79A and COVID-19: IgA antibodies were demonstrated to dominate the early humoral response to SARS-CoV-2 infection and to have stronger neutralization capacities compared with IgG40 and were found even in the absence of IgG in individuals after asymptomatic SARS-CoV-2 infection41.